Location History:
- Varese, IT (1996 - 1997)
- Verese, IT (1997)
- Monza, IT (2000)
- Saronno, IT (2002 - 2016)
Company Filing History:
7 out of 247 
3 out of 25 
2 out of 43 
Years Active: 1996-2016
Title: Ambrogio Oliva: Innovator in Proteasome Inhibition
Introduction
Ambrogio Oliva is a notable inventor based in Saronno, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of proteasome inhibitors. With a total of 13 patents to his name, Oliva's work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
Among his latest patents, Oliva has developed boronic acid compounds and boronic esters that can modulate apoptosis through the inhibition of proteasome activity. These compounds and compositions are designed for use in methods of inducing apoptosis and treating diseases associated with proteasome activity. His innovative approach offers new avenues for therapeutic interventions in cancer and other related disorders.
Career Highlights
Throughout his career, Oliva has worked with prominent companies in the pharmaceutical industry, including Cephalon, Inc. and Boehringer Mannheim Italia, S.p.a. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in his field.
Collaborations
Oliva has collaborated with esteemed colleagues such as Ernesto Menta and Raffaella Bernardini. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in biochemistry.
Conclusion
Ambrogio Oliva's contributions to the field of proteasome inhibition exemplify the impact of innovative thinking in medicine. His patents and collaborations highlight the importance of research in developing new treatments for serious health conditions.